Cargando…

Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease

Autoantibodies can be used in the early diagnosis and treatment of atherosclerosis-related diseases. Using ProtoArray(®) screening of samples from patients with atherosclerosis, the present study identified thiosulfate sulfurtransferase-like domain-containing 2 (TSTD2) as a novel atherosclerosis ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kubota, Masaaki, Zhang, Bo-Shi, Li, Shu-Yang, Yoshida, Yoichi, Wang, Hao, Adachi, Akihiko, Matsutani, Tomoo, Mine, Seiichiro, Machida, Toshio, Kamitsukasa, Ikuo, Wada, Takeshi, Aotsuka, Akiyo, Kitamura, Kenichiro, Takizawa, Hirotaka, Kuroda, Hideyuki, Iwadate, Yasuo, Hiwasa, Takaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829233/ https://www.ncbi.nlm.nih.gov/pubmed/36699658 http://dx.doi.org/10.3892/mi.2022.64

Ejemplares similares

Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases
por: Yoshida, Yoichi, et al.
Publicado: (2020)

Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction
por: Kubota, Masaaki, et al.
Publicado: (2021)

Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction
por: Wang, Hao, et al.
Publicado: (2021)

Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack
por: Yoshida, Yoichi, et al.
Publicado: (2017)

Association between serum anti-ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension
por: Li, Shu-Yang, et al.
Publicado: (2020)

Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer
por: Li, Shu-Yang, et al.
Publicado: (2023)

Elevation of Autoantibody in Patients with Ischemic Stroke
por: YOSHIDA, Yoichi, et al.
Publicado: (2018)

GADD34 activates p53 and may have utility as a marker of atherosclerosis
por: Tomiyoshi, Go, et al.
Publicado: (2023)

Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus
por: Namiki, Toshiki, et al.
Publicado: (2023)

Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas
por: Adachi-Hayama, Masayo, et al.
Publicado: (2014)

Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastoma
por: Yoshioka, Masaki, et al.
Publicado: (2018)

Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction
por: Wang, Hao, et al.
Publicado: (2017)

Serum anti‐LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases
por: Sumazaki, Makoto, et al.
Publicado: (2020)

Elevated Adiponectin Antibody Levels in Sera of Patients with Atherosclerosis-Related Coronary Artery Disease, Cerebral Infarction and Diabetes Mellitus
por: Hiwasa, Takaki, et al.
Publicado: (2016)

Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas
por: Matsutani, Tomoo, et al.
Publicado: (2012)

Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
por: Li, Shu-Yang, et al.
Publicado: (2021)

NQPC-05 BEVACIZUMAB AFTER PROGRESSION OF GLIOBLASTOMA PROLONGS PATIENT’S LIVING TIME AT HOME IN THE LAST 90 DAYS
por: Matsutani, Tomoo, et al.
Publicado: (2019)

STMO-05 SURGICAL AND FUNCTIONAL OUTCOME OF AWAKE SURGERY FOR INSULAR GLIOMA
por: Hirono, Seiichiro, et al.
Publicado: (2019)

STMO-11 Supratotal resection of Glioblastoma with Methionine PET
por: Ko, Ozaki, et al.
Publicado: (2020)

Promoter hypomethylation and overexpression of TSTD1 mediate poor treatment response in breast cancer
por: Ansar, Muhamad, et al.
Publicado: (2022)

MPC-8 Serum anti-zinc finger FYVE domain-containing protein 21 (ZFYVE21) autoantibody as a novel biomarker for oligodendroglioma IDH-mutant and 1p/19q co-deletion
por: Matsutani, Tomoo, et al.
Publicado: (2021)

Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX)
por: Machida, Toshio, et al.
Publicado: (2015)

STMO-13 PATHOLOGICAL EVALUATION AND ONCOLOGICAL OUTCOME OF FLAIRECTOMY IN PATIENTS WITH IDH1 WILD-TYPE GLIOBLASTOMA
por: Hirono, Seiichiro, et al.
Publicado: (2022)

Role of Evaluating MGMT Status and 1p36 Deletion in Radiosurgery-Induced Anaplastic Ependymoma That Rapidly and Completely Resolved by Temozolomide Alone: Case Report and Review of the Literature
por: Hirono, Seiichiro, et al.
Publicado: (2015)

Integrative Analyses Reveal Tstd1 as a Potential Modulator of HDL Cholesterol and Mitochondrial Function in Mice
por: Zheng, Adi, et al.
Publicado: (2021)

Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke
por: Hiwasa, Takaki, et al.
Publicado: (2021)

GCT-09. HEALTH AND SOCIAL ISSUES IN THE LONG-TERM GERM-CELL TUMOR SURVIVORS
por: Matsutani, Tomoo, et al.
Publicado: (2020)

STMO-3 Mid- to long-term outcome of supratotal resection of IDH1 wild-type glioblastoma based on 11C-methionine PET: a retrospective, single-center study
por: Hirono, Seiichiro, et al.
Publicado: (2021)

Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on (11)C-methionine PET: a retrospective, single-center study
por: Hirono, Seiichiro, et al.
Publicado: (2021)

Low Expression of TSTD2 Serves as a Biomarker for Poor Prognosis in Kidney Renal Clear Cell Carcinoma
por: Tang, Gonglin, et al.
Publicado: (2023)

Two Patients with Reversible Cerebral Vasoconstriction after Carotid Artery Stenting
por: Yoshida, Yoichi, et al.
Publicado: (2021)

The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
por: Ito, Masaaki, et al.
Publicado: (2023)

PATH-03. HIGH-GRADE NEUROEPITHELIAL TUMOR SHOWING BCOR IMMUNOPOSITIVITY WITHOUT EXON 15 INTERNAL TANDEM DUPLICATIONS IN A FIVE-YEAR-OLD BOY: A CASE REPORT
por: Wakita, Shogo, et al.
Publicado: (2020)

Carotid Artery Stenting for Patients with Radiation-Induced Carotid Artery Stenosis
por: Yoshida, Yoichi, et al.
Publicado: (2022)

CS-1 Cerebellar liponeurocytoma; Report of two cases with detailed metabolic, immunohistochemical, and genetic evaluations
por: Shimizu, Miyuki, et al.
Publicado: (2021)

Elevated levels of autoantibodies against EXD2 and PHAX in the sera of patients with chronic thromboembolic pulmonary hypertension
por: Naito, Akira, et al.
Publicado: (2019)

Mechanical Thrombectomy for Acute Ischemic Stroke Complicated by Bacterial Meningitis and Infective Endocarditis
por: Kubota, Masaaki, et al.
Publicado: (2020)

Molecular imaging of 1p/19q deletion in oligodendroglial tumours with (11)C-methionine positron emission tomography
por: Iwadate, Yasuo, et al.
Publicado: (2016)

Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
por: Ito, Masaaki, et al.
Publicado: (2021)

Clinicopathological and Genomic Features of Pediatric Intracranial Myxoid Mesenchymal Tumor with both of EWSR1-CREM Gene Fusion and MAP3K13 Mutation: A Case Report and Comparison with Adult Cases in the Literature
por: SASAKI, Minami, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fg210543egg49m52fkplm5d6sb